Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Laboratories falls most in nearly two months

** Indian pharmaceutical company Divi's Laboratories Ltd's
 DIVI.NS  shares down as much as 4.1% at 3,534 rupees, their
sharpest intraday loss since Aug. 12
    ** DIVI posts its lowest since Aug. 29
    ** Stock heads for a second straight session of losses
    ** DIVI top loser in Nifty pharma index .NIPHARM
    ** Almost 800,000 shares traded by 0625 GMT, 1.9x their
30-day moving avg of more than 400,000 shares
    ** Twelve of 21 brokerages rate the stock "buy" or higher, 3
"hold" and 6 "sell" or lower; their median PT is 4,173 rupees-
Refinitiv 
    ** DIVI shares down 21.2% this year, as of last close, vs
8.4% loss in pharma index .NIPHARM and 0.7% loss in blue-chip
Nifty 50 index .NSEI
 (Reporting by Yagnoseni Das in Bengaluru)
 ((yagnoseni.das@thomsonreuters.com; Mobile: +91 6001289066))

Recent news on Divi's Laboratories

See all news